CHELSEA THERAPEUTICS INTERNATIONAL
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammat... ory bowel disease and cancer. As of December 31, 2009, it was focused on its drug development resources on two clinical stage development projects: droxidopa for symptomatic NOH and other potential indications, and its portfolio of non-metabolized antifolate compounds for the treatment of rheumatoid arthritis.
CHELSEA THERAPEUTICS INTERNATIONAL
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Charlotte, North Carolina, United States
Country:
United States
Website Url:
http://www.chelseatherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(704) 341-1516
Email Addresses:
[email protected]
Total Funding:
39.02 M USD
Technology used in webpage:
IIS 6 Level 3 Communications Omniture SiteCatalyst Digg Defense Net
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Venrock
Venrock investment in Post-IPO Equity - Chelsea Therapeutics International
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management investment in Post-IPO Equity - Chelsea Therapeutics International
Official Site Inspections
http://www.chelseatherapeutics.com
- Host name: 216.21.224.199
- IP address: 216.21.224.199
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Chelsea Therapeutics International"
Chelsea Therapeutics International - Crunchbase
Organization. Chelsea Therapeutics International . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. Chelsea Therapeutics International is a pharmaceutical company developing and …See details»
Chelsea Therapeutics Company Profile 2024: Valuation, …
Chelsea Therapeutics is headquartered in Charlotte, NC. What is the size of Chelsea Therapeutics? Chelsea Therapeutics has 19 total employees. What industry is Chelsea Therapeutics in? Chelsea Therapeutics’s primary industry …See details»
Chelsea Therapeutics International - Contacts, Employees, Board …
Organization. Chelsea Therapeutics International . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 3. Number of …See details»
Chelsea Therapeutics International - ContactOut
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety …See details»
Chelsea Therapeutics International - Funding, Financials, Valuation ...
Chelsea Therapeutics International is a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases. Search Crunchbase. ... How much funding has …See details»
Chelsea Therapeutics, Inc. - VentureRadar
Chelsea Therapeutics, Inc. VentureRadar profile. Find out more about Chelsea Therapeutics, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ...See details»
Chelsea Therapeutics Company Profile | Management and
Find contact information for Chelsea Therapeutics. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Chelsea Therapeutics's email format.See details»
Chelsea Therapeutics Overview | SignalHire Company Profile
Organization Website: ChelseaRx.com : Chelsea Therapeutics industries Pharma: Headquarters Location: 3530 Toringdon Way, Charlotte, NC, 28277 US 3530 Toringdon Way, Charlot...See details»
Organization | Chelsea Therapeutics - CDEK
Organization Overview. First Clinical Trial. 2007 NCT00657046. First Marketed Drug. 2014 droxidopa . First NDA Approval. 2014 droxidopa . Last Known Activity ... Chelsea …See details»
Chelsea Therapeutics International - Products, Competitors, …
Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical company that seeks to acquire, develop and commercialize innovative products for the treatment of a variety of human …See details»
SEC.gov | HOME
Chelsea Therapeutics International, Ltd. 3530 Toringdon Way, Suite 200 Charlotte, North Carolina 28277 (704) 341-1516 ... It has experience in acquiring attractive assets and successfully …See details»
Chelsea Therapeutics’s Competitors, Revenue, Number of ... - Owler
Chelsea Therapeutics’s Profile, Revenue and Employees. Chelsea Therapeutics is a North Carolina-based pharmaceutical company that acquires and develops therapeutics for the …See details»
Chelsea Therapeutics, Inc. Pops As FDA Finally Approves NORTHERA
Feb 19, 2014 Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of …See details»
Chelsea Therapeutics Inc - Company Profile and News
Company profile page for Chelsea Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Lundbeck to buy U.S. firm Chelsea Therapeutics for up to $658 …
May 8, 2014 Danish pharmaceutical company H. Lundbeck <LUN.CO> is to buy Chelsea Therapeutics <CHTP.O> for up to $658 million in a deal that would give it the rights to the U.S. …See details»
Joseph G. Oliveto - Interim Chief Executive Officer - Crunchbase
Primary Organization . Chelsea Therapeutics International . ... 2 current jobs as President & Chief Executive Officer at Milestone Pharmaceuticals and Interim Chief Executive Officer at Chelsea …See details»
chelseatherapeutics.com - urlscan.io
Oct 23, 2024 chelseatherapeutics.com NETWORK-SOLUTIONS-HOSTING, US Seen 31 times between November 8th, 2022 and November 25th, 2022. General Info Open in SearchSee details»
Lundbeck is buying Chelsea for $658M, with a just-in-case clause
May 8, 2014 After months of speculation and Wall Street tremulance, Chelsea Therapeutics finally got its buyout deal: Lundbeck has agreed to pick up the biotech for as much as $658 …See details»
Lundbeck Gives Chelsea $658M Vote of Confidence
Chelsea Therapeutics is going out with a bang that could be as loud as $658 million.. The Charlotte pharmaceutical company announced today that it has agreed to be purchased by …See details»